Severe rhabdomyolysis and acute asymptomatic pancreatitis following the concomitant use of Biktarvy in the setting of hyperosmolar diabetic crisis

Biktarvy (bictegravir/emtricitabine/tenofovir alafemanide), which has been recently approved for the treatment of HIV, is a single-pill regimen that associates bictegravir and a novel integrase strand transfer inhibitor (INSTI) with a combination of two nucleoside reverse transcriptase inhibitors (N...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMJ Case Rep
Main Authors: Simeni Njonnou, Sylvain Raoul, Henrard, Sophie, Noure, Lamya, Goffard, Jean-Christophe
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2020
Teme:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7332188/
https://ncbi.nlm.nih.gov/pubmed/32611654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-234483
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki